— Know what they know.
Not Investment Advice

PRGO NYSE

Perrigo Company plc
1W: -7.5% 1M: -1.6% 3M: +28.6% YTD: +4.9% 1Y: -35.2% 3Y: -49.8% 5Y: -61.0%
$14.26
+0.24 (+1.71%)
 
Weekly Expected Move ±7.0%
$12 $13 $14 $15 $16
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $2.0B mcap · 138M float · 2.36% daily turnover · Short 62% of daily vol

📊 Key Metrics

TTM
$4B
Revenue
-4.2% YoY
$-1,735M
Net Income
-2060.3% YoY
$175M
Free Cash Flow
-31.8% YoY
30.7%
Gross Margin
2.3%
Op. Margin
7.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-49.6%
ROA-19.6%
ROIC3.1%

Valuation

P/E-1.1
P/B0.8
EV/EBITDA-3.5

Leverage

Debt/Equity1.31
Current Ratio2.32
Interest Cov.-8.9x

Quality Scores

Piotroski F4/9
Altman Z-0.44
Beneish M-3.69

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms